TY - JOUR
T1 - A Noninvasive Assessment of Flow Based on Contrast Dispersion in Computed Tomography Angiography
T2 - A Computational and Experimental Phantom Study
AU - Eslami, Parastou
AU - Seo, Jung Hee
AU - Rahsepar, Amir Ali
AU - Shafique, Asim
AU - Rollison, Shirley F.
AU - Lardo, Albert C.
AU - Mittal, Rajat
AU - Chen, Marcus Y.
N1 - Publisher Copyright:
Copyright © 2022 by ASME.
PY - 2022/9/1
Y1 - 2022/9/1
N2 - Transluminal attenuation gradient (TAG), defined as the gradient of the contrast agent attenuation drop along the vessel, is an imaging biomarker that indicates stenosis in the coronary arteries. The transluminal attenuation flow encoding (TAFE) equation is a theoretical platform that quantifies blood flow in each coronary artery based on computed tomography angiography (CTA) imaging. This formulation couples TAG (i.e., contrast dispersion along the vessel) with fluid dynamics. However, this theoretical concept has never been validated experimentally. The aim of this proof-of-principle phantom study is to validate TAFE based on CTA imaging. Dynamic CTA images were acquired every 0.5 s. The average TAFE estimated flow rates were compared against four predefined pump values in a straight (20, 25, 30, 35, and 40 ml/min) and a tapered phantom (25, 35, 45, and 55 ml/min). Using the TAFE formulation with no correction, the flow rates were underestimated by 33% and 81% in the straight and tapered phantoms, respectively. The TAFE formulation was corrected for imaging artifacts focusing on partial volume averaging and radial variation of contrast enhancement. After corrections, the flow rates estimated in the straight and tapered phantoms had an excellent Pearson correlation of r = 0.99 and 0.87 (p < 0.001), respectively, with only a 0.6%±0.2 mL/min difference in estimation of the flow rate. In this proof-of-concept phantom study, we corrected the TAFE formulation and showed a good agreement with the actual pump values. Future clinical validations are needed for feasibility of TAFE in clinical use.
AB - Transluminal attenuation gradient (TAG), defined as the gradient of the contrast agent attenuation drop along the vessel, is an imaging biomarker that indicates stenosis in the coronary arteries. The transluminal attenuation flow encoding (TAFE) equation is a theoretical platform that quantifies blood flow in each coronary artery based on computed tomography angiography (CTA) imaging. This formulation couples TAG (i.e., contrast dispersion along the vessel) with fluid dynamics. However, this theoretical concept has never been validated experimentally. The aim of this proof-of-principle phantom study is to validate TAFE based on CTA imaging. Dynamic CTA images were acquired every 0.5 s. The average TAFE estimated flow rates were compared against four predefined pump values in a straight (20, 25, 30, 35, and 40 ml/min) and a tapered phantom (25, 35, 45, and 55 ml/min). Using the TAFE formulation with no correction, the flow rates were underestimated by 33% and 81% in the straight and tapered phantoms, respectively. The TAFE formulation was corrected for imaging artifacts focusing on partial volume averaging and radial variation of contrast enhancement. After corrections, the flow rates estimated in the straight and tapered phantoms had an excellent Pearson correlation of r = 0.99 and 0.87 (p < 0.001), respectively, with only a 0.6%±0.2 mL/min difference in estimation of the flow rate. In this proof-of-concept phantom study, we corrected the TAFE formulation and showed a good agreement with the actual pump values. Future clinical validations are needed for feasibility of TAFE in clinical use.
KW - contrast agent
KW - coronary computed tomography
KW - noninvasive flow rate
KW - time density
KW - transluminal attenuation gradient
KW - transluminal flow encoding
UR - http://www.scopus.com/inward/record.url?scp=85128001729&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85128001729&partnerID=8YFLogxK
U2 - 10.1115/1.4053997
DO - 10.1115/1.4053997
M3 - Article
C2 - 35237785
AN - SCOPUS:85128001729
SN - 0148-0731
VL - 144
JO - Journal of Biomechanical Engineering
JF - Journal of Biomechanical Engineering
IS - 9
ER -